HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

456.818

-2.975-0.65%

Number of Gainers:9

Number of Losers:38

Number of Flat:4

PE:- -

High:462.725

Open:459.044

Low:456.197

Close:459.793

Volume:232.97M

Turnover:4.65B

Market Cap:2.89T

Float Cap:2.01T

Loading ...

Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors

Wuxi Apptec's Target Price Raised to HK$262 by CLSA on Outperform Rating

Genscript Biotech - on 14 August, Listing Committee Confirmed Company May Proceed with Proposed Spin-Off.

THOMSON REUTERS

Genscript Biotech Drops Most in 17 Months on Unit Spinoff Proposal

Citi Says Meituan-W Can Withstand Ongoing Macro and Competitive Pressures, Reaffirms Buy Rating

Chinese Pharma Companies Plan Hong Kong Listings

Genscript Biotech Proposes Spin-Off and Separate Listing of Probio Technology

Genscript Biotech Proposes Separate Listing of Subsidiary on Hong Kong Main Board

Genscript Biotech - Proposed Spin-Off and Separate Listing of Probio Technology Limited

THOMSON REUTERS

Simcere Pharmaceutical Announces Approval for Marketing of Yingmule in China by NMPA

Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment to the Co

Robot Maker's Market Value Drops Over 220 Billion Amid Slowing Growth and Management Scrutiny

Simcere Says China Approves RSV Prevention Antibody Yingmule for Infants

Simcere Pharmaceutical - Approval for Marketing of Yingmule in China by National Medical Products Administration

THOMSON REUTERS

Everest Medicines Gets China Nod for CARDAMYST Application

MT Newswires Live

ZYLOXTB (02190) Allocates HK$1.12 Million for Share Buyback on September 3

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback

Everest Medicines Says China NMPA Approves Cardamyst Nasal Spray for PSVT Conversion in Adults

Everest Medicines - Nmpa Approves Cardamyst (Etripamil) Nda for Psvt in Adults in China

THOMSON REUTERS

Executive Wang Lei Boosts Stake in China Resources Mixc Lifestyle with Fresh Share Purchase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK1583/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":456.81787,"timestamp":1789455440076,"preClose":459.79254,"halted":0,"volume":232973908,"delay":0,"changeRate":-0.00647,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-2.97467,"latestTime":"09-15 14:57:20","open":459.04364,"high":462.72455,"low":456.19675,"amount":4654653127,"amplitude":0.014197,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789459800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789435800000,1789444800000],[1789448400000,1789459200000]],"pbRate":2.082038,"peRate":43.981296,"turnoverRate":0.002246,"increases":9,"decrements":38,"flats":2,"marketCap":2894324044832,"floatMarketCap":2008277257440},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":462.72455,"amplitude":0.014197,"preClose":459.79254,"low":456.19675,"pbRate":"2.082038","latestPrice":456.81787,"volume":232973908,"delay":0,"open":459.04364,"prevYearClose":503.90085,"prevWeekClose":450.903,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":478.121,"twentyDayClose":483.539,"sixtyDayClose":401.503,"secType":"PLATE","market":"HK","turnoverRate":0.002246,"peRate":43.981296,"marketCap":2894324044832,"floatMarketCap":2008277257440,"timestamp":1789455440076,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":9,"down":38,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141408111","title":"Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1141408111","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141408111?lang=en_us&edition=fundamental","pubTime":"2026-09-04 13:34","pubTimestamp":1788500064,"startTime":"0","endTime":"0","summary":"UOB Kay Hian's latest research report indicates that mainland Chinese equities underwent a consolidation phase during August, with the Hang Seng Index and MSCI China Index retreating 1.2% and 0.4%...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999006514.SGD","LU1688375341.USD","GB00BDT5M118.USD","LU0211977185.USD","IE00B031J352.USD","BK1500","LU0011963245.USD","LU0819123356.HKD","BK1095","LU0414403682.SGD","SGXZ99366536.SGD","SG9999015952.SGD","LU1961090484.USD","LU0072913022.USD","LU0541501648.USD","06160","IE00B5MMRT66.SGD","LU0328353924.USD","LU1997245094.SGD","EMCS","SG9999015978.USD","HK0000306685.HKD","LU0384037296.USD","BK1161","LU0293314216.USD","LU0979878070.USD","LU1196710351.USD","EVS.SI","LU0067412154.USD","LU1171460220.USD","EEMX","LU1051769294.HKD","LU0228659784.USD","LU2008162690.USD","LU0348788117.USD","LU1981816686.USD","LU0972618739.USD","LU2097828631.EUR","LU0345775950.USD","LU0210527791.USD","LU1974910355.USD","LU1781817850.SGD","GAMR","AAXJ","LU0348784397.USD","LU0261950470.USD","LU2087589342.USD","LU0791590937.USD","LU0499858602.USD","LU1880383366.USD","LU2294711473.HKD","LU1769817096.USD","LU0164880469.USD","LU1048596156.SGD","LU0488056044.USD","IE00B031HW06.USD","LU0359202008.SGD","LU0449515922.USD","LU2931357623.SGD","LU3227948356.SGD","00700","LU0823413587.USD","LU1568876335.HKD","LU1917777945.USD","LU2362540622.SGD","LU1770034418.SGD","LU0128522744.USD","LU0880133367.SGD","HK0000914660.USD","LU0289960550.SGD","LU0261947096.USD","LU1224444064.USD","LU0348816934.USD","IE00B8L5B284.USD","SG9999011746.SGD","LU2362541273.HKD","LU0823397103.USD","BK1587","IE00BZ08YT58.USD","SG9999002414.USD","LU0531970944.HKD","LU1868837565.USD","LU0203345920.USD","SG9999000418.SGD","HK0000352291.HKD","JEMA","LU2476274720.SGD","SG9999001051.SGD","LU2506952253.HKD","LU0594300179.USD","LU0214875030.USD","LU2328871848.SGD","BK6516","IE00B543WZ88.USD","LU1951186391.HKD","SG9999002463.SGD","LU1807302812.USD","LU0314109678.HKD","BK1502","LU1048484197.HKD","LU3063872942.SGD","SG9999001069.SGD","BK0061","LU0786609619.USD","ONC","LU2476274308.USD","IE00BQXX3D17.EUR","LU0823413660.USD","LU1439102457.SGD","300014","LU0048580855.USD","LU0254981946.USD","BK0073","LU1196710864.SGD","LU0143863198.USD","IE00B0JY6N72.USD","LU0048597586.USD","LU1725190679.HKD","LU0918141705.HKD","IE00BQXX3F31.USD","IE0003795394.USD","ESPO","LU1226288097.SGD","BK1531","LU0577902371.SGD","LU1733274473.HKD","LU1008478684.HKD","IE00BPRC5H50.USD","LU0648948544.HKD","LU0856984785.SGD","LU0871576103.HKD","SG9999000475.SGD","LU0072462343.USD","LU0441854154.USD","LU0348783233.USD","LU0675040207.SGD","IE00B8HQ1Z84.USD","LU0049853897.USD","SGXZ49509284.SGD","LU1580142542.USD","LU2097828714.EUR","LU2125910849.SGD","LU0348723411.USD","LU0651947912.USD","LU0039217434.USD","LU1642822792.SGD","HK0000151867.HKD","SOCL","LU0868486357.SGD","LU2237443622.USD","LU2265009873.SGD","LU0737861699.HKD","LU1044874839.SGD","LU1504937902.USD","LU1993786604.SGD","LU1960683339.HKD","LU0264606111.USD","IE0034224299.USD","LU0572940350.SGD","LU1102505929.USD","LU0828238088.HKD","LU0188438112.USD","BK0072","LU0261950983.USD","LU0516422366.SGD","LU0823426480.USD","LU0210533765.USD","LU0823041008.USD","LU0210526637.USD","LU1051768304.USD","SG9999001846.SGD","LU1733274390.USD","TCHI","LU1810669033.SGD","JADE","LU2293587155.HKD","LU0348825331.USD","LU2778985437.USD","LU0049112450.USD","BK1583","LU2251237488.HKD","LU2488822045.USD","LU1323998911.USD","LU0577902298.EUR","LU0181495838.USD","LU0819121731.USD","LU1039395188.USD","LU0588545904.SGD","LU1282651121.HKD","LU2498475776.HKD","LU2177674079.SGD","SG9999014674.SGD","BK1586","IE0001KFT4U8.USD","LU0608807433.USD","LU0672654166.SGD","LU2045819591.USD","TCEHY","LU0235996351.USD","LU1152091754.HKD","LU0572939691.SGD","BK1615","BK1516","LU0878004406.USD","HK0001040143.USD","SG9999015945.SGD","LU1242518931.SGD","LU1956131251.USD","LU0531971595.HKD","LU0738912210.USD","LU1282649141.HKD","IE00B0169N27.USD","LU0052750758.USD","TCOM","BIDD","LU0326950275.SGD","LU1770036033.HKD","U10.SI","LU1146622755.USD","SG9999001689.USD","LU0269904917.USD","SG9999001093.SGD","LU2023250504.SGD","LU1568876251.USD","LU2051468812.USD","LU0043850808.USD","LU0823039010.USD","LU1868837722.USD","BK1517","LU2153591404.USD","LU0169518387.USD","LU0345769128.USD","SGXZ51526630.SGD","IE0032834883.USD","LU0499858438.USD","LU2251237306.USD","LU0737861772.HKD","LU0140636845.USD","BK1609","LU0918141887.USD","LU1196710195.USD","LU0164865239.USD","LU0823038988.USD","LU2152927971.USD","SG9999015986.USD","LU0828237510.HKD","LU0516423174.USD","LU0051755006.USD","BK6044","LU0577902538.SGD","SGXZ31699556.SGD","LU1044875133.USD","LU1242518857.USD","002008","LU0516422440.USD","LU0370786039.SGD","LU0455707207.USD","LU0634319403.HKD","LU1366334651.USD","LU1997244956.HKD","LU0244354667.USD","BK1608","LU0588545730.USD","LU0642271901.SGD","LU0345776255.USD","BK1588","IE0032431581.USD","LU0196878994.USD","HK0001040168.HKD","LU0315178854.USD","BK0251","LU0593848301.USD","LU0431992006.USD","LU0865486749.SGD","LU1734074674.USD","LU1808992512.USD","LU0633140560.USD","BK0187","LU1804176565.USD","LU0107464264.USD","BK1589","LU0106259558.USD","LU0329678170.USD","IE00B067MR52.USD","LU0251144936.SGD","LU1282648689.USD","LU2449936058.SGD","LU2237443978.SGD","LU1226288170.HKD","SGXZ81514606.USD","LU0862451837.USD","BK0028","LU0228367735.SGD","LU1328615791.USD","LU0320764243.SGD","LU0588546209.SGD","LU0878005551.USD","HK0000288784.HKD","LU1366334578.USD","LU2247934214.USD","LU0700851271.USD","LU1629966141.USD","BKF","LU2237443465.HKD","FDNI","LU0307460666.USD","BK0188","XSOE","BK0155","LU0543330566.HKD","LU0456827905.SGD","HK0000306701.USD","LDEM","LU0683595622.HKD","SG9999013353.USD","IE0003851619.USD","LU0540923850.HKD","LU0607220059.USD","LU1224709979.USD","SG9999002406.SGD","LU0274383776.USD","BK0070","IE00BZ08YR35.GBP","SG9999001226.SGD","LU2462611646.USD","LU0594300419.USD","BK1610","LU0054450605.USD","LU0320764599.SGD","SG9999002562.SGD","LU0106959298.USD","LU0163747925.USD","IE0008368411.USD","LU0640798160.USD","LU1719994722.HKD","LU2424517915.HKD","LU0650527681.SGD","LU0823426308.USD","LU0149721374.USD","HK0000165453.HKD","LU0449509016.USD","LU2097828474.EUR","LU2257852520.SGD","LU1718418525.SGD","LU0029875118.USD","LU2237443549.SGD","LU1064131003.USD","LU1226287529.USD","LU2362541513.USD","LU0708995583.HKD","LU0708995153.HKD","SG9999003461.SGD","LU2039709279.SGD","LU0165289439.USD","LU0516422952.EUR","LU0456842615.SGD","LU0417516902.SGD","LU0164872284.USD","LU0359201612.USD","LU0315179316.USD","LU2097828805.USD","LU0348805143.USD","LU1226287875.USD","LU2226246903.HKD","LU0651946864.USD","IE00BF5LJ272.USD","BK0125","HK0000288743.USD","LU1226287792.SGD","BK0077","LU2237443382.USD","LU0348783662.USD","LU2317271919.USD","IE00BQXX3C00.GBP","LU2279701549.SGD","IE00B0169L03.USD","LU2279858448.HKD","LU0359201885.HKD","LU0149534421.HKD","LU1785774172.SGD","LU1046422090.SGD","LU0192582467.USD","LU0823040885.USD","LU0128522157.USD","LU2125910500.SGD","LU0608807946.USD","LU0561508036.HKD","BK1521","LU1880383440.USD","LU0175139822.USD","BK1618","LU0054237671.USD","LU0985320562.USD","LU0417516571.SGD","LU0173614495.USD","HTCD.SI","LU0132412106.USD","LU1105468828.SGD","LU1439103000.SGD","SG9999014898.SGD","HK0000320223.HKD","LU1794554557.SGD","IE00B031HY20.USD","LU0797268264.HKD","LU2237443895.HKD","LU0396098781.USD","LU0327786744.USD","HK0000914686.HKD","HK0000320264.USD","IE00B3M56506.USD","LU1282649067.USD","LU1152091168.USD","SG9999007991.SGD","LU0259732245.USD","LU1691799644.USD","LU0231483743.USD","LU0080751232.USD","01801","BK0201","LU1048588211.SGD","LU0784639295.USD","LU0287142896.SGD","LU0084288322.USD","LU0890818403.SGD","LU0572944931.SGD","LU0516423091.SGD","LU1235295612.USD","LU1655091459.SGD","LU2348773727.SGD","688235","HK0000352382.USD","IE0031814852.USD","LU1102505762.USD","SG9999017495.SGD","LU0048575426.USD","LU0106252389.USD","LU0463099449.HKD","BK0152","LU1813983027.USD","EMC","KWEB","LU0329678337.USD","LU1251922891.USD","LU0541502299.USD","CXSE","LU0509642566.USD","LU0211331839.USD","IE0003895053.USD","LU0862451753.SGD","LU1044876610.USD","BK1604","LU2106854487.HKD","LU0605514214.HKD","LU0831103253.SGD","LU0823437842.USD","LU0886674414.USD","LU1023057109.AUD","LU1515016050.SGD","LU0047713382.USD","SGXZ90724238.SGD","002371","LU1969619763.USD","LU1211504680.USD","LU0143863784.USD","SG9999014880.SGD","LU0456846285.SGD","BK0196","LU0828237940.HKD","LU1831875114.USD","LU0117844026.USD","LU0348827113.USD","LU1769817179.HKD","LU0070217475.USD","LU0501845795.SGD","LU0469268626.HKD","LU1997245177.USD","09961","KURE","LU0326948709.USD","LU1226288253.USD","LU2289578879.USD","LU0611395673.USD","LU1481107354.HKD","SG9999014906.USD","LU1316542783.SGD","LU1282649810.SGD","LU1115378108.SGD","LU0029874905.USD","FFEM","LU2399975544.HKD","LU0502904849.HKD","LU2495084118.USD","SG9999018857.SGD","LU0061477393.USD","IE00BGV7N243.SGD","SG9999000459.SGD","LU0791591158.USD","LU0633140727.USD","IE0009570106.USD","LU0577902454.USD","LU0898667661.SGD","LU1188198961.HKD","LU2242644610.SGD","SGXZ81163826.USD","LU2133065610.SGD","SG9999002828.SGD","ODDS","SG9999018865.SGD","LU0048388663.USD","LU0588545490.SGD","LU1820825898.SGD","LU0117841782.USD","LU1655091616.SGD","LU1064130708.USD","LU1675838814.USD","LU0882747503.HKD","LU0823397285.USD","IE00B29SXG58.USD","BK0132","SG9999001903.USD","LU2097828557.USD","LU0543330483.HKD","LU0348814723.USD","SG9999004220.SGD","LU0127658192.USD","LU1282651048.USD","LU0096374516.USD","IE0008368742.USD","IE0008369823.USD","LU0417516738.SGD","SG9999006597.SGD","LU0348735423.USD","LU1720050803.USD","LU0577902611.USD","BK1526","LU0251143458.SGD","BK1164","LU0589944569.HKD","LU1303224171.USD","LU0229945570.USD","SG9999014914.USD","BK0064","LU1328277881.USD","IE00BZ08YS42.EUR","SG9999000327.SGD","LU1814569148.SGD","LU1868838027.USD","LU1883866441.USD","BK0224","BK1591","LU2089985449.USD","LU0320764755.SGD","IE00B97KM107.HKD","LU1255011170.USD","LU2148510915.USD","LU0345769631.USD","LU0821914370.USD","LU0203347892.USD","LU0873338254.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152717067","title":"Wuxi Apptec's Target Price Raised to HK$262 by CLSA on Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1152717067","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152717067?lang=en_us&edition=fundamental","pubTime":"2026-09-04 12:52","pubTimestamp":1788497548,"startTime":"0","endTime":"0","summary":"CLSA has released its latest global healthcare sector outlook, highlighting several key investment opportunities. Notably, the firm has initiated coverage on Thermo Fisher with an \"Outperform\" rating...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997244956.HKD","BK1141","LU2125910500.SGD","LU0700851271.USD","LU0572944931.SGD","LU1969619763.USD","LU0456842615.SGD","EWH","LU0320764599.SGD","BK1576","LU1770034418.SGD","IE00B543WZ88.USD","02359","LU0469268626.HKD","LU1303224171.USD","IE00B5MMRT66.SGD","LU0052750758.USD","LU1719994722.HKD","LU1934453819.USD","603259","LU2328871848.SGD","LU2488822045.USD","LU1997245177.USD","LU1997245094.SGD","LU0708995583.HKD","BK1583","LU1808992512.USD","LU2045819591.USD","BK0216","IE00BPRC5H50.USD","LU0348766576.USD","LU0348767384.USD","LU2495084118.USD","LU0327786744.USD","LU0611395673.USD","LU1046422090.SGD","LU1979443071.USD","LU1251922891.USD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386146","title":"Genscript Biotech - on 14 August, Listing Committee Confirmed Company May Proceed with Proposed Spin-Off.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386146?lang=en_us&edition=fundamental","pubTime":"2026-09-04 12:01","pubTimestamp":1788494515,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44V15E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01548","HK0000306685.HKD","BK1576","BK1141","HK0000306701.USD","HK0000320223.HKD","HK0000320264.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383125","title":"Genscript Biotech Drops Most in 17 Months on Unit Spinoff Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383125","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383125?lang=en_us&edition=fundamental","pubTime":"2026-09-04 10:17","pubTimestamp":1788488239,"startTime":"0","endTime":"0","summary":"BUZZ-Genscript Biotech drops most in 17 months on unit spinoff proposal** Shares of Genscript Biotech Corp1548.HKdrop 12% to HK$31.94, on track for biggest one-day pct decline since April 2025** Stock hits the lowest level since August 20** Top pct loser in the Hang Seng Biotech Index.HSBIO, which gains 0.9%** Genscript Biotech proposes spin-off andseparate listingof Probio Technology on the main board of the stock exchange and  the stock exchange's listing committee confirmed that the company may proceed with the proposed spin-off** Genscript will continue to hold a controlling stake in Biologics and Advanced Therapy Contract Research, Development, and Manufacturing Organization services unit after the proposed spin-off** YTD, stock up 158.9%, benchmark Hang Seng Index.HSIup 0.3%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL1N44W02B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","HK0000306685.HKD","HK0000306701.USD","BK1576","HK0000320223.HKD","BK1141","HK0000320264.USD","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197919210","title":"Citi Says Meituan-W Can Withstand Ongoing Macro and Competitive Pressures, Reaffirms Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1197919210","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197919210?lang=en_us&edition=fundamental","pubTime":"2026-09-04 10:03","pubTimestamp":1788487439,"startTime":"0","endTime":"0","summary":"Citi has released a research report maintaining a \"Buy\" rating on Meituan-W (03690) with a target price of HK$120. The firm remains confident in management's steady execution, focus on high-quality...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","LU0164880469.USD","LU0231483743.USD","LU0320764755.SGD","LU0577902538.SGD","LU1102505929.USD","LU2097828474.EUR","LU0072913022.USD","LU1688375341.USD","LU1770034418.SGD","LU0700851271.USD","LU0501845795.SGD","LU0269904917.USD","LU0509642566.USD","LU0499858602.USD","LU0823038988.USD","LU1064131003.USD","LU0502904849.HKD","LU1734074674.USD","LU0605514214.HKD","LU1188198961.HKD","LU0417516902.SGD","LU0672654166.SGD","LU0543330483.HKD","LU0828237510.HKD","LU0047713382.USD","SG9999002463.SGD","LU0326948709.USD","LU0577902611.USD","LU0049853897.USD","SG9999014674.SGD","LU0348814723.USD","LU0149721374.USD","IE00BF5LJ272.USD","LU0819123356.HKD","LU1868837565.USD","LU0918141705.HKD","LU0499858438.USD","LU0072462343.USD","LU0164865239.USD","LU1675838814.USD","LU0211977185.USD","LU1993786604.SGD","LU0348788117.USD","LU2045819591.USD","BK1142","MPNGY","LU0577902454.USD","IE00B543WZ88.USD","LU0828237940.HKD","LU0011963245.USD","LU0214875030.USD","LU1807302812.USD","LU2778985437.USD","LU0084288322.USD","IE00B031HY20.USD","LU0823426308.USD","LU1719994722.HKD","LU0043850808.USD","LU1794554557.SGD","LU0633140727.USD","LU1720050803.USD","LU0823426480.USD","IE00B3M56506.USD","LU0456827905.SGD","LU0737861699.HKD","LU0823039010.USD","LU0878005551.USD","LU0173614495.USD","LU0633140560.USD","BK1233","BK1618","LU0463099449.HKD","BK1589","BK1615","LU1328615791.USD","LU0048580855.USD","LU0871576103.HKD","LU0572944931.SGD","BK1591","LU0348735423.USD","LU2148510915.USD","IE0032431581.USD","LU0588545490.SGD","LU0868486357.SGD","LU2242644610.SGD","IE00B29SXG58.USD","LU0611395673.USD","LU0228659784.USD","LU0039217434.USD","LU0880133367.SGD","SG9999002828.SGD","LU0456846285.SGD","LU0683595622.HKD","LU0821914370.USD","LU0588545730.USD","LU0132412106.USD","LU0140636845.USD","LU0359201885.HKD","BK1575","LU0210526637.USD","LU0594300179.USD","LU1808992512.USD","LU0307460666.USD","LU1226287529.USD","LU0577902371.SGD","LU0455707207.USD","LU0819121731.USD","LU0348825331.USD","LU0067412154.USD","LU0196878994.USD","LU1770036033.HKD","LU2152927971.USD","LU1064130708.USD","LU0326950275.SGD","LU2097828714.EUR","LU1008478684.HKD","LU0251144936.SGD","SG9999002562.SGD","SG9999001689.USD","SG9999001903.USD","BK1604","LU1813983027.USD","LU0143863784.USD","LU0348816934.USD","LU1048588211.SGD","IE00B5MMRT66.SGD","LU1481107354.HKD","LU2488822045.USD","HMTD.SI","IE0008368742.USD","LU0029875118.USD","LU1303224171.USD","LU2125910500.SGD","LU2097828805.USD","BK1521","LU0449509016.USD","IE0008369823.USD","LU0577902298.EUR","LU0164872284.USD","LU0417516738.SGD","LU0431992006.USD","LU0261950983.USD","LU0540923850.HKD","LU1023057109.AUD","LU0856984785.SGD","IE0034224299.USD","LU0314109678.HKD","LU1328277881.USD","LU2087589342.USD","LU1242518857.USD","LU0320764599.SGD","BK1583","LU1960683339.HKD","LU0589944569.HKD","LU2097828631.EUR","IE00B0JY6N72.USD","LU0823040885.USD","LU2476274308.USD","LU0359201612.USD","LU0979878070.USD","LU0348805143.USD","LU0359202008.SGD","LU0531971595.HKD","LU0823041008.USD","LU0593848301.USD","LU0594300419.USD","LU0873338254.USD","LU1242518931.SGD","LU1048596156.SGD","LU2226246903.HKD","LU0054450605.USD","03690","LU2039709279.SGD","LU0054237671.USD","LU0561508036.HKD","BK1610","LU1102505762.USD","LU1152091168.USD","LU0650527681.SGD","LU1880383440.USD","LU0181495838.USD","LU0106252389.USD","LU1251922891.USD","LU0865486749.SGD","LU1868838027.USD","KWEB","LU0348827113.USD","LU1152091754.HKD","IE00BPRC5H50.USD","SG9999000327.SGD","LU0345775950.USD","LU0128522157.USD","LU0287142896.SGD","LU0588546209.SGD","LU1868837722.USD","LU1880383366.USD","LU0165289439.USD","LU0244354667.USD","SG9999000459.SGD","LU0117841782.USD","LU0345776255.USD","LU2476274720.SGD","LU1282648689.USD","LU2399975544.HKD","LU1105468828.SGD","LU0051755006.USD","LU0634319403.HKD","LU1323998911.USD","LU0588545904.SGD","LU0541501648.USD","LU0052750758.USD","LU0541502299.USD","LU0327786744.USD","LU0370786039.SGD","LU2097828557.USD","LU0449515922.USD","LU0797268264.HKD","LU0315178854.USD","LU0048597586.USD","LU1831875114.USD","LU2257852520.SGD","LU0143863198.USD","LU0918141887.USD","LU0828238088.HKD","LU1224709979.USD","LU1961090484.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664068388","title":"Chinese Pharma Companies Plan Hong Kong Listings","url":"https://stock-news.laohu8.com/highlight/detail?id=2664068388","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664068388?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:43","pubTimestamp":1788486180,"startTime":"0","endTime":"0","summary":"Two Chinese pharmaceutical companies have lined up listings in Hong Kong, as the sector forms the next wave of offerings in the city.Shenzhen Salubris Pharmaceuticals has applied for a Hong Kong listi","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","01548","002294","BK0196","BK1576","HK0000306701.USD","BK1141","BK0188","BK1583","HK0000320264.USD","BK0239","BK0187","BK0183","HK0000320223.HKD","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887743","title":"Genscript Biotech Proposes Spin-Off and Separate Listing of Probio Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887743","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887743?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:41","pubTimestamp":1788486096,"startTime":"0","endTime":"0","summary":"Sept 4 (Reuters) - Genscript Biotech Corp <1548.HK>::*PROPOSED SPIN-OFF AND SEPARATE LISTING OF PROBIO TECHNOLOGY LIMITED*Further company coverage: 1548.HK* ((Reuters.Briefs@thomsonreuters.com;))((Reu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nRSD3Nq84j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","HK0000320264.USD","BK1583","HK0000320223.HKD","BK1576","HK0000306701.USD","01548","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173333530","title":"Genscript Biotech Proposes Separate Listing of Subsidiary on Hong Kong Main Board","url":"https://stock-news.laohu8.com/highlight/detail?id=1173333530","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173333530?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:24","pubTimestamp":1788481450,"startTime":"0","endTime":"0","summary":"Genscript Biotech (01548) has announced a proposal to spin off and independently list its indirect non-wholly owned subsidiary, Probio Technology Limited (\"Probio\"), on the Main Board of the Stock...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","IPOS","HK0000306685.HKD","BK1576","HK0000320264.USD","HK0000306701.USD","BK1583","HK0000320223.HKD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807248","title":"Genscript Biotech - Proposed Spin-Off and Separate Listing of Probio Technology Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664807248?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:13","pubTimestamp":1788480830,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44V17A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000320264.USD","BK1576","HK0000306701.USD","HK0000320223.HKD","HK0000306685.HKD","BK1141","BK1583","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803692","title":"Simcere Pharmaceutical Announces Approval for Marketing of Yingmule in China by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803692","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803692?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:51","pubTimestamp":1788450718,"startTime":"0","endTime":"0","summary":"BRIEF-Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPASept 3 (Reuters)-Simcere Pharmaceutical Group Ltd2096.HK:APPROVAL FOR MARKETING OF YINGMULE IN CHINA BY NATIONAL MEDICAL PRODUCTS ADMINISTRATIONFurther company coverage:2096.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664480867","title":"Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment to the Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2664480867","media":"Reuters","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664480867?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:56","pubTimestamp":1788447419,"startTime":"0","endTime":"0","summary":"Sept 3 (Reuters) - Milestone Pharmaceuticals Inc::*MILESTONE PHARMACEUTICALS ANNOUNCES NMPA APPROVAL OF ETRIPAMIL NASAL SPRAY FOR PSVT IN CHINA, MARKING FIRST REGULATORY APPROVAL OF ETRIPAMIL OUTSIDE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nRSD1Mvfn1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK4007","01952","MIST","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143469671","title":"Robot Maker's Market Value Drops Over 220 Billion Amid Slowing Growth and Management Scrutiny","url":"https://stock-news.laohu8.com/highlight/detail?id=1143469671","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143469671?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:42","pubTimestamp":1788442968,"startTime":"0","endTime":"0","summary":"Unitree Technology, the humanoid robot leader that recently went public on the A-share market, is facing mounting scrutiny over its internal management practices even as its stock price has...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","LU0164880469.USD","LU0231483743.USD","LU0320764755.SGD","LU0577902538.SGD","LU1102505929.USD","METmain","LU0072913022.USD","LU2097828474.EUR","LU1688375341.USD","LU1770034418.SGD","LU0700851271.USD","LU0501845795.SGD","LU0269904917.USD","LU0509642566.USD","LU0499858602.USD","LU0823038988.USD","LU1064131003.USD","LU0502904849.HKD","LU1734074674.USD","LU0605514214.HKD","LU1188198961.HKD","LU0417516902.SGD","LU0672654166.SGD","LU0543330483.HKD","LU0828237510.HKD","LU0047713382.USD","SG9999002463.SGD","LU0326948709.USD","LU0577902611.USD","LU0049853897.USD","SG9999014674.SGD","LU0348814723.USD","LU0149721374.USD","IE00BF5LJ272.USD","LU0819123356.HKD","LU1868837565.USD","LU0918141705.HKD","LU0499858438.USD","LU0072462343.USD","LU0164865239.USD","LU1675838814.USD","LU0211977185.USD","LU1993786604.SGD","LU0348788117.USD","LU2045819591.USD","PBOT","BK1142","MPNGY","LU0577902454.USD","IE00B543WZ88.USD","LU0828237940.HKD","IPOS","LU0011963245.USD","LU0214875030.USD","LU1807302812.USD","LU2778985437.USD","RTOO","LU0084288322.USD","IE00B031HY20.USD","LU0823426308.USD","LU1719994722.HKD","LU0043850808.USD","LU1794554557.SGD","LU0633140727.USD","LU1720050803.USD","LU0823426480.USD","IE00B3M56506.USD","LU0456827905.SGD","LU0737861699.HKD","LU0823039010.USD","LU0878005551.USD","LU0173614495.USD","LU0633140560.USD","BK1233","BK1618","LU0463099449.HKD","BK1589","BK1615","LU1328615791.USD","LU0048580855.USD","LU0871576103.HKD","LU0572944931.SGD","BK1591","LU0348735423.USD","LU2148510915.USD","IE0032431581.USD","LU0588545490.SGD","LU0868486357.SGD","LU2242644610.SGD","IE00B29SXG58.USD","LU0611395673.USD","LU0228659784.USD","LU0039217434.USD","LU0880133367.SGD","SG9999002828.SGD","LU0456846285.SGD","LU0683595622.HKD","LU0821914370.USD","LU0588545730.USD","LU0132412106.USD","LU0140636845.USD","LU0359201885.HKD","BK1575","LU0210526637.USD","LU0594300179.USD","LU1808992512.USD","ROBT","LU0307460666.USD","LU1226287529.USD","LU0577902371.SGD","LU0455707207.USD","LU0819121731.USD","LU0348825331.USD","IQM","LU0067412154.USD","LU0196878994.USD","LU1770036033.HKD","LU2152927971.USD","ROBO","LU1064130708.USD","LU0326950275.SGD","LU2097828714.EUR","LU1008478684.HKD","LU0251144936.SGD","SG9999002562.SGD","SG9999001689.USD","SG9999001903.USD","BK1604","LU1813983027.USD","LU0143863784.USD","LU0348816934.USD","LU1048588211.SGD","IE00B5MMRT66.SGD","LU1481107354.HKD","LU2488822045.USD","HMTD.SI","IE0008368742.USD","LU0029875118.USD","LU1303224171.USD","LU2125910500.SGD","LU2097828805.USD","BK1521","LU0449509016.USD","IE0008369823.USD","LU0577902298.EUR","LU0164872284.USD","LU0417516738.SGD","LU0431992006.USD","LU0261950983.USD","LU0540923850.HKD","LU1023057109.AUD","LU0856984785.SGD","IE0034224299.USD","LU0314109678.HKD","LU1328277881.USD","LU2087589342.USD","LU1242518857.USD","LU0320764599.SGD","BK1583","LU1960683339.HKD","LU0589944569.HKD","LU2097828631.EUR","IE00B0JY6N72.USD","LU0823040885.USD","BK4209","LU2476274308.USD","LU0359201612.USD","LU0979878070.USD","LU0348805143.USD","LU0359202008.SGD","LU0531971595.HKD","LU0823041008.USD","LU0593848301.USD","LU0594300419.USD","LU0873338254.USD","LU1242518931.SGD","LU1048596156.SGD","LU2226246903.HKD","UBOT","WDRN","LU0054450605.USD","03690","LU2039709279.SGD","LU0054237671.USD","LU0561508036.HKD","BK1610","LU1102505762.USD","LU1152091168.USD","LU0650527681.SGD","LU1880383440.USD","LU0181495838.USD","LU0106252389.USD","LU1251922891.USD","LU0865486749.SGD","LU1868838027.USD","KWEB","LU0348827113.USD","LU1152091754.HKD","IE00BPRC5H50.USD","SG9999000327.SGD","LU0345775950.USD","LU0128522157.USD","LU0287142896.SGD","LU0588546209.SGD","LU1868837722.USD","LU1880383366.USD","LU0165289439.USD","LU0244354667.USD","SG9999000459.SGD","LU0117841782.USD","LU0345776255.USD","LU2476274720.SGD","LU1282648689.USD","LU2399975544.HKD","LU1105468828.SGD","DRAG","LU0051755006.USD","LU0634319403.HKD","LU1323998911.USD","LU0588545904.SGD","BK4122","LU0541501648.USD","LU0052750758.USD","LU0541502299.USD","LU0327786744.USD","LU0370786039.SGD","LU2097828557.USD","LU0449515922.USD","LU0797268264.HKD","KOMP","LU0048597586.USD","LU0315178854.USD","LU1831875114.USD","LU2257852520.SGD","LU0143863198.USD","LU0918141887.USD","LU0828238088.HKD","LU1224709979.USD","LU1961090484.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877598","title":"Simcere Says China Approves RSV Prevention Antibody Yingmule for Infants","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877598","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877598?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:27","pubTimestamp":1788442055,"startTime":"0","endTime":"0","summary":"Simcere says China approves RSV prevention antibody Yingmule for infantsChina’s NMPA cleared Yingmule (culevibart injection) for marketing on Sept. 3, 2026.Product targets RSV prevention in newborns a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLb65jvV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877568","title":"Simcere Pharmaceutical - Approval for Marketing of Yingmule in China by National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877568","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877568?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:27","pubTimestamp":1788442041,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874018","title":"Everest Medicines Gets China Nod for CARDAMYST Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874018","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874018?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:40","pubTimestamp":1788439214,"startTime":"0","endTime":"0","summary":"Everest Medicines  obtained approval for the new drug application of CARDAMYST from China's National Medical Products Administration.The drug is for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia to sinus rhythm in adults, according to a Thursday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01952","BK1574","BK1583","MDCO","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159831479","title":"ZYLOXTB (02190) Allocates HK$1.12 Million for Share Buyback on September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1159831479","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159831479?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:24","pubTimestamp":1788438277,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) declared that on September 3, 2026, the company repurchased 52,500 shares at an aggregate cost of roughly HK$1.1219 million.The shares were bought back at a price range of HK$21.18 to HK$21.52 each.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02190","BK1574","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874561","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874561","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874561?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:17","pubTimestamp":1788437861,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share buybackZylox-Tonbridge repurchased 52,500 H shares on Sept. 3, 2026 for treasury.Buyback price range HKD 21.18 to HKD 21.52; aggregate co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL70MPxB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1587","BK1574","BK1583","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664087437","title":"Everest Medicines Says China NMPA Approves Cardamyst Nasal Spray for PSVT Conversion in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2664087437","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664087437?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:15","pubTimestamp":1788437722,"startTime":"0","endTime":"0","summary":"Everest Medicines says China NMPA approves Cardamyst nasal spray for PSVT conversion in adultsChina’s NMPA cleared the NDA for CARDAMYST (etripamil) nasal spray to convert acute PSVT episodes to sinus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLbRghy4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","01952","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871033","title":"Everest Medicines - Nmpa Approves Cardamyst (Etripamil) Nda for Psvt in Adults in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871033","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871033?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:06","pubTimestamp":1788437196,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0KG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01952","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188828400","title":"Executive Wang Lei Boosts Stake in China Resources Mixc Lifestyle with Fresh Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1188828400","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188828400?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:34","pubTimestamp":1788435276,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on September 1, Wang Lei increased his holdings in CHINA RES MIXC (01209) by 50,000 shares. The transaction was executed at a price of HKD 38.52 per...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0164939612.USD","00241","LU0456827905.SGD","LU0620787316.HKD","BK1515","BK1229","BK1617","LU0082770016.SGD","BK1571","BK1142","BK1247","BK1501","01209","BK1589","LU0051755006.USD","LU0456846285.SGD","BK1502","BK1584","BK1615","BK1542","BK1583","EWH","HK0000165453.HKD","LU0082770016.USD","BK1189","BK1258","BK1591","BK1610"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":13,"totalSize":354,"code":"91000000","status":"200"}]}}